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ABSTRACT
Objectives: Diabetic retinopathy (DR) is one of the microvascular complications in Type 2 diabetes (T2D). Elevated serum uric acid (SUA) has been 
shown to play a significant role in DR and nephropathy, but there is little information on retinopathy. Therefore, this study was aimed to investigate 
the SUA and lipid profile in T2D patients with and without DR and the association between SUA and severity of DR.
Methods: The study was conducted in the ophthalmology OPD at Sri Lakshmi Narayana Institute of Medical Sciences. The presence of T2D was 
confirmed by investigating fasting blood glucose level (normal limit <110 mg/dl) in all the individuals. DR was examined by detailed dilated 
fundoscopic examination. Based on the fundus examination, patients were divided into diabetes with signs of DR and those without signs of DR. Age 
and sex matched healthy were taken as controls. Fasting blood sugar, SUA, and lipid profile were investigated for these groups.
Results: The study found elevated SUA and abnormal lipid profile in DR group when compared to non-DR and control groups. We also found the 
significant association between SUA and severity of DR, particularly in males.
Conclusion: We found a significant association between SUA and severity of DR in T2D patients. Further studies with the large sample size are needed 
to establish the role of elevated SUA and the mechanism involved in the pathogenesis of retinopathy in diabetic patients. Regular measurements of 
SUA level could be advised to the diabetic patients for the early management.
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INTRODUCTION
Diabetic retinopathy (DR) is one of the chronic microvascular 
complications in Type 2 diabetes (T2D) caused by the deleterious 
metabolic effects of hyperglycemia, which results in extensive and 
early neurodegeneration [1]. DR is a major cause of vision loss in 
adults [2], which contributes to severe morbidity in patients with 
diabetes, resulting in significant public health issue. Chronic exposure 
to the metabolic changes with respect to diabetes may damage the 
microvasculature of the retina, resulting in DR [3]. In recent decades, 
serum uric acid (SUA) has been emerging as a potential risk factor 
for T2D. Deranged biochemical profile of SUA has been shown to 
play a significant role in development of diabetic neuropathy and 
nephropathy [4], but there is little information available on association 
between SUA and DR. Thus, identifying a clinical marker is very 
important for early detection and management of progression of DR. If 
uric acid finds to be a novel screening tool that predicts future incidence 
of T2D, it might be useful for early implementation of interventions 
to mitigate the risk especially for patients with complications of DR. 
Therefore, this study was aimed to investigate the SUA and lipid profile 
in patients of T2D with and without retinopathy and the association 
between SUA and severity of DR in T2D patients.
METHODS
The study was conducted with 50 T2D patients who attended outpatient 
department, Department of Ophthalmology in collaboration with 
Department of Biochemistry, Sri Lakshmi Narayana Institute of Medical 
Sciences, Puducherry, from August 2015 to September 2016.
The age group selected for the study was 35-70 years. The study was 
approved by Institutional Human Ethical Committee. An informed 
consent was obtained from all the patients employed for the study.
Inclusion and exclusion criteria
The presence of T2D was confirmed by investigating fasting blood 
glucose level (normal limit <110 mg/dl) in all the individuals. Based on 
the test results, they were included for the study. The exclusion criteria 
were patients with Type 1 DM, those who were pregnant, those treated 
for cancer in the past 5 years before study enrollment, those with blood 
disorders causing hemolysis (e.g., hemolytic anemia), kidney transplant 
recipients, and those with chronic glomerulonephritis. Further subjects 
with hypertension, arthritis, myocardial infarction or other major 
systemic associations which are known to be associated with deranged 
uric acid level were excluded.
Demographic and medical data of the patients were collected by 
reviewing medical records and direct patient interview which included 
age, gender, and duration of diabetes.
Assessment of DR
DR was examined by performing detailed dilated fundoscopic 
examination by slit lamp and Topcon TRC50DX Fundus Camera (Topcon 
Medical systems, Inc. NJ, USA) as per the standard criteria [5]. Based 
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on the fundus examination, patients were divided into diabetes with 
signs of DR and those without signs of DR. Patients with retinopathy 
(DR group) were classified into non-proliferative diabetic retinopathy 
(NPDR) and PDR.
Study protocol
The patients were grouped as follows:
Group I: 50 subjects of age and sex matched healthy controls
Group II: 25 subjects with T2D for more than 5 years without signs of DR
Group III: 25 subjects with T2D for more than 5 years with signs of DR.
Biochemical estimations
Blood samples were collected from all individuals. About 5 ml 
of blood was withdrawn from overnight fasted individuals in 
ethylenediaminetetraacetic acid coated wells, and the blood was 
allowed to clot for serum separation which is used for the measurement 
of lipid profile and uric acid level.
FBS was estimated by GOD-POD method and HbA1C by turbidometric 
method. SUA was assessed by uricase method. Serum triglycerides 
(TG) and total cholesterol (TC) were measured by enzymatic methods, 
glycerol 3 phosphate oxidase N-ethyl sulfopropyl anisidine and 
cholesterol oxidase-peroxidase endpoint methods, respectively. Serum 
high-density lipoprotein (HDL) was estimated by enzyme selective 
protection method. Serum low-density lipoprotein (LDL) and very LDL 
was calculated using Fried Wald’s formula.
Statistical analysis
Data were analyzed using SPSS statistical software (version 22, SPSS, 
Inc., Chicago, Illinois, USA). Data were expressed as mean±SD. Student’s 
t-test was used to compare and asses the significance between the 
groups. A value of p<0.05 was considered statistically significant.
RESULTS
Table 1 shows the mean values of all biochemical parameters. Increased 
level of FBS was observed in Groups II and III as compared to Group I. 
Group III patients particularly males have higher FBS than females and 
as compared to Group II males and females and the significance found 
was p<0.00. Patients of Group III male had higher HbA1c as compared 
to Groups I and II suggesting poor glycemic control (increased HbA1c). 
It is clear from the table that there was an increase incidence of DR as 
an increase in duration of disease.
An elevated uric acid level is a known major risk factor of diabetic 
microvascular diseases; next, we assessed SUA level in all the groups. 
A highly significant difference was noted when compared the Groups I 
and III (p<0.000) and when comparing Groups II and III, Group III male 
had a higher level of SUA and found significance (p<0.00) suggests they 
could have high risk of developing DR.
Association of dyslipidemia with DR is also a subject of considerable 
importance. Hence, we analyzed lipid profile in all the three groups. 
Increased levels of TG, TC and LDL cholesterol, and decreased HDL 
were observed in Groups II and III when compared to Group I indicating 
there is a relationship between abnormal lipid profile and DR.
Table 2 and Fig. 1 shows the association between SUA and severity of DR in 
T2D patients. 25 patients in the DR group were graded as NPDR and PDR 
based on the severity. The level of SUA was significantly higher in males of 
PDR group as compared to NPDR, and non-DR males are representing SUA 
level may reflect the severity of DR in patients with T2D.
DISCUSSION
In this study, SUA was shown to be a risk factor for DR in T2D 
patients. In addition, this notion was supported by a recent study 
that the more severe DR, the more elevated level of SUA [6]. These 
findings are consistent with the previous studies by Lee et al. 2014 
and Fukui et al. 2008 [7,8]. Our findings revealed that an increased 
level of SUA was associated with the severity of DR in patients 
with T2D of males, and suggested that an elevated SUA level may 
reflect the severity of microvascular complications in patients with 
diabetes.
Table 1: Relationship between serum uric acid and lipid profile in T2D patients with and without DR













Group I versus 
Group II 
Group I versus 
Group III
Group II versus 
Group III
Male Female  Male Female Male Female
Age (years) 52.8±6.6 53±7.3 58±8.1 57±7.7 65±8.8 64±9.2 - - - - - -
Duration of 
diabetes (years)
- - 7.4±0.9 6.9±0.75 12.2±5.1 10.4±3.4 - - - - 0.00* 0.01
FBS (mg/dl) 100±23.2 96±19.3 142±45.8 116±39.4 178±86.1 149±51.3 0.00* 0.02 0.000** 0.000** 0.00* 0.02
HbA1c (%) 5.5±0.6 4.8±0.5 9.7±4.2 7.8±3.3 13.1±5.3 9.4±4.3 0.00* 0.01 0.000** 0.00* 0.000** 0.03
Uric acid (mg/dl) 4.3±1.0 4.1±0.9 5.9±2.1 4.3±1.1 7.8±3.2 5.2±2.2 0.03 0.78 0.000** 0.042 0.00* 0.046
TG (mg/dl) 144±23.4 141±22 162±34 160±36 188±48.6 173±39.2 0.02 0.04 0.000** 0.00* 0.01 0.04
TC (mg/dl) 156±20.2 153±39 183±36 171±29 221±56 198±39 0.03 0.042 0.00* 0.00* 0.02 0.04
HDL (mg/dl) 50.1±6.8 49.4±5.9 44.2±11 44.5±10.2 39.7±6.8 40.4±6.2 0.04 0.05 0.00* 0.01 0.03 0.07
LDL (mg/dl) 102±13 104±12 128±23 119±19 146±32 126±26 0.03 0.06 0.00* 0.02 0.02 0.08
VLDL (mg/dl) 28.7±12.1 27.4±11 35±23 34.1±21 35±8.8 34.7±7.3 0.05 0.06 0.05 0.06 0.72 0.76
CON: Control, Non-DR: Nondiabetic retinopathy, DR: Diabetic retinopathy, TG: Triglycerides, TC: Total cholesterol, HDL: High-density lipoprotein, LDL: Low-density 
lipoprotein, VLDL: Very low-density lipoprotein, *p<0.00 significant, **p<0.000 highly significant
Fig. 1: Serum uric acid concentration in severity of diabetic 
retinopathy (DR), serum uric acid concentration in non‑diabetic 
retinopathy (Non‑DR), non‑proliferative DR (NPDR) and 
proliferative DR groups, aSignificant as compared to Non‑DR 
(p<0.01), bSignificant as compared to NPDR (p<0.00)
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The role of uric acid in subjects with T2D with or without complications 
of DR has been studied, and some studies showed similar and dissimilar 
results. Some studies showed a low level of SUA in diabetic patients [9,10]. 
Interestingly, some studies showed hyperuricemia in patients with 
T2D and they have suggested that uric acid play an important role in 
worsening the insulin resistance by inhibiting the bioavailability of nitric 
oxide, which is essential for insulin-stimulated glucose uptake [11,12]. In 
addition, a study suggested higher level of uric acid in subjects of diabetes 
with retinopathy and they have suspected the pro-oxidant role of uric 
acid in causation of oxidative stress leading to diabetic complication like 
DR and they could not clearly state that the hyperuricemia in DR is either 
a protective response (due to its antioxidant role) or a primary cause of it 
(due to its pro-oxidant role) [13].
Studies reported the elevated level of SUA and are increasing in the 
severity of DR in patients with T2D [7,14]. We also found a similar 
result in DR patients, especially in males. Krizova et al., 2011, reported 
that the vitreous concentrations of SUA were significantly higher in 
patients with diabetes than in nondiabetic controls [15,16]. It has been 
reported in a study that uric acid in the diabetic group was higher when 
compared to a healthy individual [17]. An increased concentration of 
SUA in vascular endothelial growth factor (VEGF) in the vitreous fluid 
has also been demonstrated in patients with DR [18]. Further Funatsu 
et al., 2005, and Selim et al., 2010, reported that the aqueous and 
vitreous levels of VEGF were found to be significantly correlated with 
the severity of DR [19,20] thus suggesting the hypothesis that SUA a 
contributory factor to the progression and severity of DR.
Association of dyslipidemia with DR is an emerging area of research 
to have considerable deliberation. Many remarkable studies have 
shown a significantly strong association of hypercholesterolemia and 
LDL-cholesterol with severity of retinal hard exudates [21,22]. In 
support of this, our study also found altered lipid profile and it was 
significant in DR patients than non-DR patients. It is well-established 
that low HDL-C is a risk factor for development of the complication of 
diabetes, which is further supported in this study.
CONCLUSION
We found a significant association between increased level of SUA and 
severity of DR in patients with T2D and were especially seen in males. 
Further studies with the large sample size are needed to establish the 
role of elevated SUA and the mechanism involved in the pathogenesis 
of retinopathy in diabetic patients. Regular measurements of SUA level 
could be advised to the diabetic patients for the early management from 
the severity of microvascular diseases. Hence, this study may put forth 
that SUA could be a better diagnostic tool to assess DR.
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Table 2: Association between serum uric acid and severity of DR
Parameter Non‑DR DR p‑value
NPDR 10 PDR 15
Male (n=14) Female (n=11) Male (n=07) Female (n=3) Male (n=11) Female (n=04)
Serum uric acid (mg/dl) 4.5±0.8 4.1±0.7 5.9±1.9 4.5±1.2 7.6±3.1 5.8±2.6 0.01
Non-DR: Nondiabetic retinopathy, DR: Diabetic retinopathy, PDR: Proliferative retinopathy
